BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3556420)

  • 1. PC13 embryonal carcinoma cells produce a heparin-binding growth factor.
    van Veggel JH; van Oostwaard TM; de Laat SW; van Zoelen EJ
    Exp Cell Res; 1987 Apr; 169(2):280-6. PubMed ID: 3556420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PC13 embryonal carcinoma-derived growth factor.
    Heath JK; Isacke CM
    EMBO J; 1984 Dec; 3(12):2957-62. PubMed ID: 6526007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence.
    Milner PG; Li YS; Hoffman RM; Kodner CM; Siegel NR; Deuel TF
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1096-103. PubMed ID: 2610682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a macrophage-derived heparin-binding growth factor.
    Besner G; Higashiyama S; Klagsbrun M
    Cell Regul; 1990 Oct; 1(11):811-9. PubMed ID: 2088527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
    Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
    Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of polypeptide growth factors secreted by murine embryonal carcinoma cells.
    van Zoelen EJ; Ward-van Oostwaard TM; Nieuwland R; van der Burg B; van den Eijnden-van Raaij AJ; Mummery CL; De Laat SW
    Dev Biol; 1989 May; 133(1):272-83. PubMed ID: 2651184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-binding growth factor isolated from human prostatic extracts.
    Mydlo JH; Bulbul MA; Richon VM; Heston WD; Fair WR
    Prostate; 1988; 12(4):343-55. PubMed ID: 3393496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney.
    Mydlo JH; Heston WD; Fair WR
    J Urol; 1988 Dec; 140(6):1575-9. PubMed ID: 3193547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial characterization of mitogenic activity of ovine corpora lutea from early pregnancy.
    Grazul-Bilska AT; Redmer DA; Zheng J; Killilea SD; Reynolds LP
    Growth Factors; 1995; 12(2):131-44. PubMed ID: 8679247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of different molecular and chromatographic forms of heparin-binding growth factor 1 from bovine brain.
    McKeehan WL; Crabb JW
    Anal Biochem; 1987 Aug; 164(2):563-9. PubMed ID: 2445228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatography of amino acids, peptides and proteins. LXXIV. Separation of heparin-binding growth factors by reversed-phase high-performance liquid chromatography.
    Hearn MT; Guthridge M; Bertolini J
    J Chromatogr; 1987 Jun; 397():371-8. PubMed ID: 3654827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial characterization of endothelial mitogens produced by bovine corpora lutea from the estrous cycle.
    Grazul-Bilska AT; Redmer DA; Killilea SD; Zheng J; Reynolds LP
    Biochem Cell Biol; 1993; 71(5-6):270-7. PubMed ID: 7506042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts.
    Quinkler W; Maasberg M; Bernotat-Danielowski S; Lüthe N; Sharma HS; Schaper W
    Eur J Biochem; 1989 Apr; 181(1):67-73. PubMed ID: 2714282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of mitogenic factor(s) by ovine corpora lutea throughout the estrous cycle.
    Grazul-Bilska AT; Redmer DA; Killilea SD; Kraft KC; Reynolds LP
    Endocrinology; 1992 Jun; 130(6):3625-32. PubMed ID: 1375905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further purification of human pituitary-derived chondrocyte growth factor: heparin-binding and cross-reactivity with antiserum to basic FGF.
    Too CK; Murphy PR; Hamel AM; Friesen HG
    Biochem Biophys Res Commun; 1987 May; 144(3):1128-34. PubMed ID: 3579954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free culture of PC13 murine embryonal carcinoma cells.
    Heath JK; Deller MJ
    J Cell Physiol; 1983 Jun; 115(3):225-30. PubMed ID: 6853605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multiple heparin-binding growth factor species by murine embryonal carcinoma and embryonic stem cells.
    Heath JK; Paterno GD; Lindon AC; Edwards DR
    Development; 1989 Sep; 107(1):113-22. PubMed ID: 2627890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor.
    Ueno N; Baird A; Esch F; Shimasaki S; Ling N; Guillemin R
    Regul Pept; 1986 Dec; 16(2):135-45. PubMed ID: 3809608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine pituitary heparin-binding fibroblast growth factors: acidic and basic forms.
    Ho PL; Caron E; Armelin HA; Gambarini AG
    Braz J Med Biol Res; 1988; 21(2):203-12. PubMed ID: 3203156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of heparin-binding growth factors from porcine uterus.
    Brigstock DR; Heap RB; Barker PJ; Brown KD
    Biochem J; 1990 Feb; 266(1):273-82. PubMed ID: 2310377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.